Literature DB >> 33902587

Assessment of training and mentoring for DR-TB care decentralization in Tanzania.

Dennis Lyakurwa1, Johnson Lyimo2, Christiaan Mulder3,4, Puck T Pelzer3, Inge Koppelaar3, Marleen Heus3.   

Abstract

INTRODUCTION: Drug-resistant TB (DR-TB) care shifted from centralized to decentralized care in Tanzania in 2015. This study explored whether DR-TB training and mentoring supported healthcare workers' (HCWs) DR-TB care performance.
METHODS: This mixed study assessed HCWs' DR-TB care knowledge, the training quality, and the mentoring around 454 HCWs who were trained across 55 DR-TB sites between January 2016 and December 2017. Pre- and post-training tests, end-of-training evaluation, supervisor's interviews, DR-TB team self-assessment and team focus group discussion were conducted among trained HCWs. Interim and final treatment results of the national central site and the decentralized sites were compared.
RESULTS: HCW's knowledge increased for 15-20% between pre-training and post-training. HCWs and supervisors perceived mentoring as most appropriate to further develop their DR-TB competencies. Culture negativity after 6 months of treatment was similar for the decentralized sites compared to the national central site, 81% vs 79%, respectively, whereas decentralized sites had less loss to follow-up (0% versus 3%) and fewer deaths (3% versus 12%). Delays in laboratory results, stigma, and HCWs shortage were reported the main challenges of decentralized care.
CONCLUSIONS: Training and mentoring to provide DR-TB care at decentralized sites in Tanzania improved HCWs' knowledge and skills in DR-TB care and supported observed good interim and final patient treatment outcomes despite health system challenges.

Entities:  

Keywords:  HCWs capacity building; MDR-TB treatment; Treatment outcomes

Year:  2021        PMID: 33902587     DOI: 10.1186/s12960-021-00600-4

Source DB:  PubMed          Journal:  Hum Resour Health        ISSN: 1478-4491


  1 in total

1.  Tuberculosis patient care decentralised to district clinics with community-based directly observed treatment in a rural district of South Africa.

Authors:  M E Edginton
Journal:  Int J Tuberc Lung Dis       Date:  1999-05       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.